Health
New head lice treatment approved for use in USA – Mirage News
L – R Hatchtech CEO Hugh Alsop, Associate Professor Vern Bowles and Hatchtech Chairman Paul Kelly. Photo: supplied. A new prescription head lice…
L – R Hatchtech CEO Hugh Alsop, Associate Professor Vern Bowles and Hatchtech Chairman Paul Kelly. Photo: supplied.
A new prescription head lice treatment, developed by University of Melbourne Associate Professor Vern Bowles, has been given Food and Drug Administration (FDA) approval, allowing it to be sold in the USA.
The treatment, Xeglyze™, was developed by Hatchtech, an Australian pharmaceutical company and will be commercialised by Dr Reddy’s Laboratories.
Hatchtech CEO Hugh Alsop estim…
-
Noosa News18 hours agoMan arrested following alleged armed rape and kidnapping in Maroochydore
-
General11 hours agoEmergency operation underway after reports of bodies north-east of Falls Creek
-
Noosa News14 hours agoRetail worker allegedly raped at gunpoint before 3½-hour kidnapping ordeal
-
Noosa News13 hours agoPSPA declared, Camp Mountain – Sunshine Coast